Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 2, 2013, Pages 276-286

  Lin, Chih Hung ^a   Fang, Yi Ping ^a   Al Suwayeh, Saleh Abdulah ^b   Yang, Shih Yung ^c,d   Fang, Jia You ^d  

^a CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Antibacterial activity; Nanoemulsion; Nanostructured lipid carrier; Percutaneous absorption; Tetracycline; Tretinoin

Indexed keywords

CATIONIC SURFACTANT; LIPID; NANOCARRIER; NANOMATERIAL; RETINOIC ACID; TETRACYCLINE;

AGAR DIFFUSION; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; AQUEOUS SOLUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; FEMALE; GROWTH INHIBITION; IN VITRO STUDY; MOUSE; NANOCHEMISTRY; NANOEMULSION; NANOENCAPSULATION; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; REVIEW; SKIN ABSORPTION; SKIN PERMEABILITY; STAPHYLOCOCCUS AUREUS; ZETA POTENTIAL;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG CARRIERS; EMULSIONS; FEMALE; KERATOLYTIC AGENTS; LIPIDS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; SKIN; SKIN ABSORPTION; STAPHYLOCOCCUS AUREUS; TETRACYCLINE; TRETINOIN;

EID: 84874097793     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00793     Document Type: Review

References (49)

1. Nakatsuji T, Kao MC, Fang J.Y., Zouboulis CC, Zhang L, Gallo RL, Huang CM Antimicrobial property of lauric acid against Propioni-bacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol., 129, 2480-2488 (2009).
2. Date AA, Naik B, Nagarsenker MS Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol. Physiol., 19, 2-16 (2006).
3. Ourique AF, Melero A, de Bona da Silva C, Schaefer UF, Pohlmann AR, Guterres SS, Lehr CM, Kostka KH, Beck RCR. improved photostability and reduced skin permeation of tretinoin: development of a semisolid nanomedicine. Eur. J. Pharm. Biopharm., 79, 95-101 (2011).
4. Bergstrom KG. Beyond tretinoin: cosmeceuticals for aging skin. J. Drugs Dermatol., 8, 674-677 (2009).
5. Fu JJJ, Hillebrand GG, Raleigh P, Li J., Marmor MJ, Bertucci V, Grimes PE, Mandy S.H., Perez MI, Weinkle SH, Kaczvinsky JR A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen. Br. J. Dermatol., 162, 647-654 (2010).
6. Manconi M, Sinico C, Caddeo C., Vila AO, Valenti D, Fadda AM Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int. J. Pharm., 412, 37-46 (2011).
7. Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Release, 66, 115-126 (2000).
8. Pople PV, Singh KK Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS Pharm Sci Tech, 7, 91 (2006).
9. Castro GA, Oliveira CA, Mahecha G.A., Ferreira LAM. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch. Dermatol. Res., 303, 513-520 (2011).
10. Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm., 366, 170-184 (2009).
11. Puglia C, Blasi P, Rizza L., Schoubben A, Bonina F, Rossi C., Ricci M. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int. J. Pharm., 357, 295-304 (2008).
12. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J. Am. Acad. Dermatol., 49, S200-S210 (2003).
13. Lin YK, Huang ZR, Zhuo R.Z., Fang JY Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int. J. Nanomedicine, 5, 117-128 (2010).
14. Chaidemenos GC. Tetracycline and niacinamide in the treatment of blistering skin diseases. Clin. Dermatol., 19, 781-785 (2001).
15. Coenye T, Honraet K, Rossel B., Nelis HJ Biofilms in skin infections: Propionibacterium acnes and acne vulgaris. Infect. Disord. Drug Targets, 8, 156-159 (2008).
16. Skyttä E, Mattila-Sandholm T. A quantitative method for assessing bacteriocins and other food antimicrobials by automated turbidometry. J. Microbiol. Methods, 14, 77-88 (1991).
17. Finn RK. Theory of agar diffusion methods for bioassay. Anal. Chem., 31, 975-977 (1959).
18. Stecová J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, Seltmann H, Korting HC, Kramer KD, Schäfer-Korting M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res., 24, 991-1000 (2007).
19. Castro GA, Coelho AL, Oliveira C.A., Mahecha GA, Oréfice RL, Ferreira LAM. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int. J. Pharm., 381, 77-83 (2009).
20. Castro GA, Oréfice RL, Vilela JMC, Andrade MS, Ferreira LAM. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J. Microencapsul., 24, 395-407 (2007).
21. Lim SJ, Kim CK Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int. J. Pharm., 243, 135-146 (2002).
22. Küchler S., Abdel-Mottaleb M, Lamprecht A., Radowski MR, Haag R, Schäfer-Korting M. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int. J. Pharm., 377, 169-172 (2009).
23. Hada N, Hasegawa T, Takahashi H., Ishibashi T, Sugibayashi K. Cultured skin loaded with tetracycline HCl and chloramphenicol as dermal delivery system: mathematical evaluation of the cultured skin containing antibiotics. J. Control. Release, 108, 341-350 (2005).
24. Wu Y, Fassihi R. Stability of metronidazole, tetracycline HCl and famotidine alone and in combination. Int. J. Pharm., 290, 1-13 (2005).
25. Fang JY, Fang CL, Liu C.H., Su YH Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. J. Pharm. Biopharm., 70, 633-640 (2008).
26. Shah KA, Date AA, Joshi M.D., Patravale VB Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm., 345, 163-171 (2007).
27. Sloan KB, Wasdo S. Designing for topical delivery: prodrugs can make the difference. Med. Res. Rev., 23, 763-793 (2003).
28. Lee WR, Pan TL, Wang P.W., Zhuo RZ, Huang CM, Fang JY Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination. J. Control. Release, 128, 200-208 (2008).
29. García-Fernández RA, Pérez-Martínez C, Espinosa-Alvarez J, García-Iglesias MJ. In vivo long-term effects of retinoic acid exposure in utero on induced hyperplastic epidermal foci in murine skin. Vet. Dermatol., 18, 287-293 (2007).
30. Tang XH, Vivero M, Gudas LJ Overexpression of CRABPi in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid. Exp. Cell Res., 314, 38-51 (2008).
31. Shim J, Seok Kang H, Park WS, Han S.H., Kim J., Chang IS Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J. Control. Release, 97, 477-484 (2004).
32. Müller R.H., Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv. Drug Deliv. Rev., 59, 522-530 (2007).
33. 10-Loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int. J. Pharm., 377, 207-214 (2009).
34. Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J. Pharm. Sci., 99, 21-50 (2010).
35. Baspinar Y, Keck CM, Borchert HH Development of a positively charged prednicarbate nanoemulsion. Int. J. Pharm., 383, 201-208 (2010).
36. Kitagawa S, Kasamaki M. Enhanced delivery of retinoic acid to skin by cationic liposomes. Chem. Pharm. Bull., 54, 242-244 (2006).
37. Ghouchi Eskandar N., Simovic S, Prestidge CA Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol. Pharm. Res., 26, 1764-1775 (2009).
38. Küchler S., Radowski MR, Blaschke T, Dathe M., Plendl J, Haag R, Schäfer-Korting M, Kramer KD. Nanoparticles for skin penetration enhancement - a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur. J. Pharm. Biopharm., 71, 243-250 (2009).
39. Gollnick H, Schramm M. Topical drug treatment in acne. Dermatology (Basel), 196, 119-125 (1998).
40. Chen H, Chang X, Du D., Liu W, Liu J, Weng T., Yang Y, Xu H, Yang X. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release, 110, 296-306 (2006).
41. Knorr F, Lademann J, Patzelt A., Sterry W, Blume-Peytavi U, Vogt A. Follicular transport route - research progress and future perspectives. Eur. J. Pharm. Biopharm., 71, 173-180 (2009).
42. Grange PA, Chéreau C, Raingeaud J., Nicco C, Weill B, Dupin N., Batteux F. Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin. PLoS Pathog., 5, e1000527 (2009).
43. Fernandez J, Hilliard JJ, Abbanat D, Zhang W., Melton JL, Santoro CM, Flamm RK, Bush K. in vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 54, 116-125 (2010).
44. Liu PF, Lo CW, Chen C.H., Hsieh MF, Huang CM Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections. Curr. Drug Metab., 10, 875-884 (2009).
45. Cogen AL, Nizet V, Gallo RL Skin microbiota: a source of disease or defence? Br. J. Dermatol., 158, 442-455 (2008).
46. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. Int. J. Dermatol., 46, 1-11 (2007).
47. Lukowski G, Lindequist U, Mundt S., Kramer A, Jülich WD. inhibition of dermal MRSA colonization by microalgal micro-and nanoparticles. Skin Pharmacol. Physiol., 21, 98-105 (2008).
48. Xing K, Chen XG, Kong M, Liu C.S., Cha DS, Park HJ Effect of oleoyl-chitosan nanoparticles as a novel antibacterial dispersion system on viability, membrane permeability and cell morphology of Escherichia coli and Staphylococcus aureus. Carbohydr. Polym., 76, 17-22 (2009).
49. Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. J. Biomed. Nanotechnol., 3, 317-331 (2007).